Plant breeding: Let's have some green genetic engineering!

On June 17, 2026, the European Parliament made a significant decision regarding genetically modified plants, marking a turning point in agricultural policy within the European Union. The new regulations allow certain genetic modification techniques—specifically those involving the CRISPR-Cas method—to be used without stringent risk assessments, liability requirements, or mandatory labeling. This change has been widely seen as favorable for biotechnology firms, seed breeders, and agribusiness conglomerates, who now have greater flexibility in developing and commercializing their products. However, the implications for consumers and environmental protection remain subjects of debate and concern.

The decision comes after years of strict regulations on traditional genetic engineering, which were largely shaped by public pressure and concerns over health and environmental risks. These earlier rules effectively created a near-ban on genetically modified organisms (GMOs) in Europe. With the advent of newer gene-editing technologies such as CRISPR-Cas, however, the regulatory landscape needed updating. Unlike older methods that involve inserting foreign DNA into plant genomes, CRISPR allows for precise modifications using the plant's own genes, akin to natural mutations that have occurred over millennia through conventional breeding practices.

CRISPR technology enables scientists to make targeted changes to plant DNA, allowing them to develop crops that are more resilient to diseases, pests, and environmental stressors. According to reports, this technique can reduce the time required to create new crop varieties from ten years to eight. Some strains developed using CRISPR have already been approved in countries like Japan and the United States, and their cultivation areas are expanding steadily. Regulatory bodies and scientific organizations have stated there is currently no evidence suggesting these foods pose any health risks.

Critics argue that while the technology offers potential benefits, its widespread use could lead to increased reliance on large corporations rather than smaller, independent breeders. However, some mid-sized plant breeders suggest that CRISPR does not necessarily require expensive laboratory equipment or high-tech infrastructure, making it accessible to a broader range of players in the industry. Additionally, concerns about consumer choice and the ability to purchase non-GMO products appear unfounded. Traditional GMOs continue to be subject to existing regulations, and organic food remains exempt from the new guidelines. Retail chains and producer associations might introduce voluntary labeling systems based on customer demand, potentially even promoting products labeled as free from genetic modification.

The issue of patentability under the new rules has also sparked discussion. While protecting intellectual property rights is important, overly restrictive patent laws could hinder competition among breeders. Currently, breeders can freely use seeds from competitors to develop new varieties. If future patents impose prohibitively high licensing fees, they could slow down innovation and progress in the field.

As the new regulations take effect, the focus will shift toward monitoring their impact on agriculture, consumer behavior, and the environment. There is anticipation that this technological advancement could lead to a surge in bio-based products, offering both economic opportunities and ecological benefits. However, the long-term effects of these changes remain uncertain and will likely depend on how the technology is implemented and regulated moving forward.